Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction

Bosnian Journal of Basic Medical Sciences

Volumn 9, Issue 4, 2009, Pages 301-306

  Dizdarević Hudić, Larisa ^a   Kušljugić, Zumreta ^a   Baraković, Fahir ^a   Brkić, Selmira ^b   Sabitović, Damir ^a   Jahić, Elmir ^a   Isabegović, Maida ^a   Smajić, Elnur ^a   Hudić, Igor ^a   Divković, Katarina ^a  

^a UNIVERSITY CLINICAL CENTRE TUZLA   (Bosnia and Herzegovina)

^b UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

Author keywords

Acute myocardial infarction; Anti inflammatory; Cytokines; HDL; Pro inflammatory

Indexed keywords

EID: 73849094331     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2009.2784     Document Type: Article

References (25)

1. Fuster V., Badimon L., Badimon J., et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J.Med. 1992; 326:242-250.
2. Davies M.J., Woolf N., Rowles P., et al. Morphology of the en-dothelium over the atherosclerotic plaques in human coronary arteries. Br. Heart J. 1988; 60:459-464.
3. Davies M.J. Pathophysiology of acute coronary syndromes. Heart. 2000; 83; 361-366.
4. Mulvihill N.T., Foley J.B. Inflammation in acute coronary syndromes. Heart. 2002; 87:201-204.
5. Torzewski M., Rist C.Mortensen R.F. et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler. hromb. Vasc. Biol. 2000; 20:2094-2099.
6. Kilic T., Ural D., Ural E., et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary yndrome. Heart. 2006;92:1041-1046
7. Corti R., Fuster V., Badimon J.J. Pathogenetic concepts of acute coronary syndromes. J. Am. Coll. Cardiol. 2003; 41:7S-14S.
8. Hajjar D.P., Haberland M.E. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 1997; 272:22975-22978.
9. Paoletti R., Gotto A.M. Jr, Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004; 109 (23 Suppl 1) : III20-26.
10. Simon A.D, Yazdani S., Wang W., et al. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J. Thromb. Thrombolysis. 2000; 9:217-222.
11. Smith D.A., Irving S.D., Sheldon E, et al. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001; 104:746-749.
12. Biasucci L.M, Vitelli A., Liuzzo G. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996; 94: 874-877.
13. Dybdahl B., Slordahl S.A., Waage A., et al. Myocardial ischemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart. 2005; 91: 299-304.
14. Kotajima N., Kimura T., Tsugiyasu K., et al. Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction. Heart. 2001; 86: 704-705.
15. Li D., Zhao D. Kinetics of tumor necrosis factor α in plasma and the cardioprotective effects of a monoclonal antibody to tumour necrosis factor α in acute myocardial infarction. Am. Heart. J. 1999; 137: 1145-1152.
16. Waehre T., Halvorsen B., Damas J.K. Inflammatory imbalance between IL-10 and TNF alpha in unstable angina potential plaque stabilizing effects of IL-10. Eur. J. Clin. Invest. 2002; 2:803-810.
17. Blake G.J, Ridker P.M. Novel clinical markers for vascular wall inflammation. Circ. Res. 2001; 89:763-771.
18. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., et al. Serum tumour necrosis factor α, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coronary artery disease. 2003; 14(6): 431-438. (Pubitemid 37070321)
19. Shibata M., Endo S., Inada K. Elevated plasma levels of interleu-kin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J. Interferon Cytokine Res. 1997; 17: 145-150.
20. (20) Alam S.E., Nasser S.S., Fernainy K.E. Cytokine imbalance in acute coronary syndrome. Curr. Opin. Pharmacol. 2004; 4: 166-170.
21. Frangogiannis N.G., Mendoza L.H., Lindsey M.L. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J. Immunol. 2000; 165: 2798-2808.
22. Yip H.K., Youseff A.A., Chang L.T., et al. Association of Interleukin-10 Level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circ. J. 2007; 71: 1086-1091.
23. Malarstig A., Eriksson P., Hamsten A., et al. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart. 2008; 94:724-729.
24. Tziakas N.D., Chalikiasa G.K., Hatzinikolaoua H.I., et al. Anti-inflammatory cytokine profile in acute coronary syndromes: behaviour of interleukin-10 in association with serum etallopro-teinases and proinflammatory cytokines. Int. J. Cardiol. 2004; 92: 169-175.
25. Gomarasci M., Basilico N., Sisto F., et al. High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli. Biochim. Biophys. Acta. 2005; 1736 (2): 136-143.